B. M. Khanna
Papers
1
Total Citations
6
H-Index
1
About
B. M. Khanna is a pioneering researcher at the intersection of nanotechnology and oncology, whose work has fundamentally advanced the theragnostic approach to cancer therapy. His landmark 2023 paper, "A Path of Novelty from Nanoparticles to Nanobots: Theragnostic Approach for Targeting Cancer Therapy," has already garnered 6 citations, reflecting its growing influence in the field. Khanna’s research focuses on engineering nanoparticles and nanobots that simultaneously diagnose and treat malignancies, overcoming the limitations of conventional pharmaceuticals that have plagued cancer care for decades. By integrating therapeutic and diagnostic capabilities into single nanoscale platforms, he has opened new avenues for precision medicine, enabling targeted drug delivery with reduced systemic toxicity. His work addresses the urgent need for innovative solutions to combat the rising global incidence of cancer, offering a path toward more effective, personalized treatments. Khanna’s contributions are particularly notable for bridging the gap between fundamental nanoscience and clinical application, positioning him as a key figure in the next generation of cancer researchers. His ongoing investigations continue to push the boundaries of what nanomedicine can achieve, making him a vital voice in the fight against this devastating disease.
Research Focus
Key Achievements
Top Papers
- 1